Investor Alert: Canopy Growth (TSX:WEED) Falls 15% in the Last Month and Aurora Cannabis (TSX:ACB) Reports a Disappointing Quarter

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock falls from April highs and Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) reports a disappointing quarter as the market remains volatile.

| More on:
Road sign warning of a risk ahead

Image source: Getty Images.

The S&P/TSX Composite Index is 2.5% below its highs at the time of writing today, as the broad market selloff continues.

With this, we are seeing increasingly nervous investors that are becoming more aware of the risks out there and less willing to overlook them.

As far as risk goes, the cannabis industry is certainly fraught with it, if only for the reason that this industry is new, so there will be growing pains, unexpected setbacks, and increased volatility in this growth stage.

Along with the huge potential for this industry, we get huge risks, and this makes sense because, as we know, higher potential rewards usually mean taking higher risk.

Let’s look at two of the biggest cannabis companies and get an update on them and their stock price performance in the last month or so.

Aurora Cannabis (TSX:ACB)(NYSE:ACB)

Revenue in Aurora’s third quarter 2019 was 367% higher than last year and 21% higher than last quarter. Strong growth, indeed. The problem here, and the reason for the weakness in the stock price initially after the results were released, is that this revenue is below expectations, and this is a stock that is factoring in big expectations.

Aurora’s adjusted EBITDA loss of $36.6 million was an improvement but also below expectations. The company still expects to achieve positive adjusted EBITDA beginning in the fourth quarter of 2019.

In more good news, costs were down (by 26%), but offsetting this a bit was the fact that the selling price was also down (by 5.9).

At the time of writing, Aurora Cannabis stock is down more than 7% from April highs in a month that has seen much market weakness and a general nervousness in the market.

This, combined with Aurora’s latest results and the risks in its business and valuation, will likely take the stock lower over the shorter term at least.

Canopy Growth (TSX:WEED)(NYSE:CGC)

Canopy Growth stock is down approximately 15% since mid-April at a time when general market weakness is taking hold amid trade tensions and stock markets that are still flirting with all-time highs.

Canopy Growth will be reporting its results on June 20, with consensus expectations calling for a loss of $0.23 per share. This compares to a loss of $0.31 in the same quarter last year and a loss of $0.38 last quarter.

Final thoughts

In closing, in an increasingly nervous market, cannabis stocks are not the best investments, especially when they are still trading at such lofty valuations and factoring in such aggressive growth targets.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »